Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
Top Cited Papers
Open Access
- 1 October 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 63 (10), 1079-1087
- https://doi.org/10.1001/archpsyc.63.10.1079
Abstract
Research from JAMA Psychiatry — Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia — Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)This publication has 21 references indexed in Scilit:
- Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled TrialsAmerican Journal of Psychiatry, 2003
- A Meta-analysis of the Efficacy of Second-Generation AntipsychoticsArchives of General Psychiatry, 2003
- New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysisThe Lancet, 2003
- A systematic review of atypical antipsychotic drugs in schizophreniaHealth Technology Assessment, 2003
- Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ, 2000
- Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of lifeSchizophrenia Research, 2000
- Measures of quality of life among persons with severe and persistent mental disordersSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1996
- A depression rating scale for schizophrenicsSchizophrenia Research, 1990
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit SyndromeSchizophrenia Bulletin, 1984